We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$21.6B
AUM Growth
+$2.85B
Cap. Flow
+$1.11B
Cap. Flow %
5.1%
Top 10 Hldgs %
30.93%
Holding
1,357
New
41
Increased
770
Reduced
236
Closed
79

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$203M
2
NOW icon
ServiceNow
NOW
+$181M
3
PSA icon
Public Storage
PSA
+$132M
4
ELS icon
Equity Lifestyle Properties
ELS
+$129M
5
OHI icon
Omega Healthcare
OHI
+$114M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$188M
2
SNOW icon
Snowflake
SNOW
+$152M
3
IRM icon
Iron Mountain
IRM
+$149M
4
PLD icon
Prologis
PLD
+$131M
5
AMT icon
American Tower
AMT
+$100M

Sector Composition

Rank Sector Weight
1 Real Estate 41.83%
2 Technology 20.16%
3 Communication Services 6.63%
4 Financials 5.64%
5 Consumer Discretionary 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
1126
Arrowhead Research
ARWR
$12.1B
$8K ﹤0.01%
426
– –
HRMY icon
1127
Harmony Biosciences
HRMY
$2.07B
$8K ﹤0.01%
189
– –
JANX icon
1128
Janux Therapeutics
JANX
$915M
$8K ﹤0.01%
187
– –
KROS icon
1129
Keros Therapeutics
KROS
$199M
$8K ﹤0.01%
133
– –
NVAX icon
1130
Novavax
NVAX
$1.21B
$8K ﹤0.01%
652
+120
+23% +$1.55K
VCEL icon
1131
Vericel Corp
VCEL
$2.39B
$8K ﹤0.01%
190
+35
+23% +$1.67K
VERA icon
1132
Vera Therapeutics
VERA
$2.39B
$8K ﹤0.01%
182
– –
BEAM icon
1133
Beam Therapeutics
BEAM
$2.7B
$7K ﹤0.01%
283
– –
FTRE icon
1134
Fortrea Holdings
FTRE
$1.96B
$7K ﹤0.01%
328
– –
MIRM icon
1135
Mirum Pharmaceuticals
MIRM
$6.84B
$7K ﹤0.01%
188
+40
+27% +$1.6K
MNKD icon
1136
MannKind Corp
MNKD
$1.21B
$7K ﹤0.01%
1,058
– –
NVCR icon
1137
NovoCure
NVCR
$1.89B
$7K ﹤0.01%
422
-4,620
-92% -$83.8K
SUPN icon
1138
Supernus Pharmaceuticals
SUPN
$2.77B
$7K ﹤0.01%
209
+52
+33% +$1.62K
VRNA
1139
DELISTED
Verona Pharma
VRNA
$7K ﹤0.01%
244
– –
ARVN icon
1140
Arvinas
ARVN
$529M
$6K ﹤0.01%
252
– –
DVAX
1141
DELISTED
Dynavax Technologies
DVAX
$6K ﹤0.01%
529
+150
+40% +$1.65K
IRON icon
1142
Disc Medicine
IRON
$2.85B
$6K ﹤0.01%
113
+54
+92% +$2.54K
KURA icon
1143
Kura Oncology
KURA
$826M
$6K ﹤0.01%
297
+70
+31% +$1.42K
LGND icon
1144
Ligand Pharmaceuticals
LGND
$5.94B
$6K ﹤0.01%
63
– –
NRIX icon
1145
Nurix Therapeutics
NRIX
$2.51B
$6K ﹤0.01%
245
+93
+61% +$2.11K
RCKT icon
1146
Rocket Pharmaceuticals
RCKT
$343M
$6K ﹤0.01%
304
– –
SNDX icon
1147
Syndax Pharmaceuticals
SNDX
$1.74B
$6K ﹤0.01%
314
– –
XLF icon
1148
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$6K ﹤0.01%
134
+27
+25% +$1.18K
ARDX icon
1149
Ardelyx
ARDX
$1.25B
$5K ﹤0.01%
754
– –
BCRX icon
1150
BioCryst Pharmaceuticals
BCRX
$2.48B
$5K ﹤0.01%
692
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2024 Portfolio in Review

As of Q3 2024, Daiwa Securities Group held 1,357 positions worth $21.6B, up 15% from $18.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $1.11B of net new capital in Q3 2024, opening 41 new positions and adding to 770 existing holdings. Its largest new stake was Lineage Inc: 465,245 shares worth $36.5M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $188M trimmed.

  • Daiwa Securities Group's largest Q3 2024 buy was Lineage Inc: 465,245 shares worth $36.5M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2024, an estimated $203M increase.
  • Daiwa Securities Group's biggest Q3 2024 reduction was Tesla, cutting an estimated $188M.
  • Daiwa Securities Group fully exited Lam Research in Q3 2024, selling an estimated $26.6M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $21.6B portfolio in Q3 2024.
  • Daiwa Securities Group opened 41 new positions and closed 79 in Q3 2024.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $21.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2024, filed 12 Nov 2024.